Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01053156 · ClinicalTrials.gov registry record · NA
Trial of Minocycline to Treat Children With Fragile X Syndrome
A NA study of Fragile X Syndrome, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT01053156 is a NA study of Fragile X Syndrome that has completed, run by University of California, Davis. The registered enrollment target is 66 participants, below the 98-participant average among 16 other Fragile X Syndrome trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01053156, a NA study of Fragile X Syndrome, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single center study at the UC Davis MIND Institute in patients age 3.5-16 years of age with fragile X syndrome (FXS), funded by a National Fragile X Foundation Grant. It is a controlled trial of minocycline, an antibiotic commonly used in children for infection or for treatment of neurodegenerative disorders. We are investigating its use in FXS because it lowers matrix metalloproteinase 9 (MMP9) levels, which are high in FXS, and it also strengthens brain connections in the animal models of FXS. We hypothesize that minocycline will likely be helpful for language, behavior and/or cognition in fragile X patients.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG minocycline hydrochloride
Study Locations (1)
California
- M.I.N.D. Institute at University of California at Davis Medical Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01053156
The ClinicalTrials.gov registry entry for NCT01053156 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 98-participant average among 16 other Fragile X Syndrome trials with a reported enrollment target (33% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fragile X Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01053156 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01053156 about?
NCT01053156 is a clinical study titled "Trial of Minocycline to Treat Children With Fragile X Syndrome". This is a single center study at the UC Davis MIND Institute in patients age 3.5-16 years of age with fragile X syndrome (FXS), funded by a National Fragile X Foundation Grant. It is a controlled trial of minocycline, an antibiotic commonly used in children for infection or for treatment of neurodeg...
What is the current status of trial NCT01053156?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2010-01. Estimated completion is 2011-12.
What conditions does trial NCT01053156 study?
This clinical trial studies the following conditions: Fragile X Syndrome.
What interventions are being tested in trial NCT01053156?
The interventions under investigation include: Placebo (DRUG), minocycline hydrochloride (DRUG).
Who is sponsoring clinical trial NCT01053156?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01053156 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fragile X Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG- Infant
RECRUITING · NA
-
Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)
RECRUITING · NA
-
Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG-Preschool Age
RECRUITING · NA
-
Speech-in-noise Perception in Autism and Fragile X
RECRUITING · NA
-
Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.